Pulmonary function in preterm infants following treatment with intravenous indomethacin.
Pulmonary function tests, including measurements of arterial blood gas levels, total pulmonary compliance, and arterial-alveolar oxygen ratios, were performed in 38 ventilator-dependent preterm infants with respiratory distress syndrome who weighed less than 1500 g at birth. Twenty-seven had a physiologically significant patent ductus arteriosus (PDA). Twelve were assigned at random to receive three doses of intravenous indomethacin, 0.2 mg/kg per dose, on the fourth day of life. This treatment resulted in ductal closure in seven infants by the seventh day of life. Another concurrently observed group of 15 infants with PDA received no indomethacin. A third group of 11 infants lacked evidence of a PDA. Pulmonary function in the infants who received indomethacin did not differ significantly from that in the other two groups.
Krauss
A N
AN
Perinatology Center, Cornell University Medical College, New York, NY.
Fatica
N
N
Lewis
B S
BS
Cooper
R
R
Thaler
H T
HT
Cirrincione
C
C
O'Loughlin
J
J
Levin
A
A
Engle
M A
MA
Auld
P A
PA
D004374:Ductus Arteriosus, Patent / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D006819:Hyaline Membrane Disease / Q000150:complications / Q000503:physiopathology*; D007213:Indomethacin / Q000494:pharmacology*; D007231:Infant, Newborn; D007234:Infant, Premature; D008168:Lung / Q000187:drug effects* / Q000503:physiopathology; D012121:Respiration, Artificial
D007213:Indomethacin